Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Development of Over-the-Counter Opioid Overdose Reversal Medication
Our Commitment to Safety as we Navigate Coronavirus
Mar 24, 2020
We have always been guided by our core values—Collaboration, Integrity, Courage, and Innovation—but now, facing the challenges posed by COVID-19, our core values have taken on new meaning. The health and safety of our colleagues, customers and community, along with the continuity of business operations – critical to serve patients who rely on our medicines and products – are our top priorities.
When it comes to teens navigating the issue of substance use and substance use disorder, The Children’s Center of Hamden in Connecticut knows that prioritizing realistic progress, offering teens alternatives, and providing the support to seek treatment services – on their own terms – makes all the difference.
How an optimistic problem solver and non-profit CEO is working with community organizations and non-profits to understand their most pressing challenges and connect them with resources to bring solutions to life.
Receiving from Purdue Pharma more than $100 million as part of a settlement of litigation brought by the state, the National Center for Wellness & Recovery (NCWR) at Oklahoma State University is remarkably positioned to accelerate work to address and abate the opioid crisis.